Redmile Group Revenue and Competitors

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • Redmile Group's estimated annual revenue is currently $15M per year.(i)
  • Redmile Group's estimated revenue per employee is $200,000

Employee Data

  • Redmile Group has 75 Employees.(i)
  • Redmile Group grew their employee count by 36% last year.

Redmile Group's People

NameTitleEmail/Phone
1
Founder & Portfolio ManagerReveal Email/Phone
2
General Counsel and Chief Compliance OfficerReveal Email/Phone
3
VP, Growth EquityReveal Email/Phone
4
VPReveal Email/Phone
5
Managing DirectorReveal Email/Phone
6
Managing DirectorReveal Email/Phone
7
Managing DirectorReveal Email/Phone
8
Managing Director/PartnerReveal Email/Phone
9
Managing DirectorReveal Email/Phone
10
Managing DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M6-40%N/AN/A
#2
N/A28-18%N/AN/A
#3
$7.5M7-12%N/AN/A
#4
$3.5M7952%N/AN/A
#5
N/A1318%N/AN/A
#6
$7.5M26-7%N/AN/A
#7
$15M4612%N/AN/A
#8
$15M34N/AN/AN/A
#9
$7.5M2624%N/AN/A
#10
$15M32867%N/AN/A
Add Company

What Is Redmile Group?

Redmile Group is a company based out of San Francisco.

keywords:N/A

N/A

Total Funding

75

Number of Employees

$15M

Revenue (est)

36%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Redmile Group News

2022-04-20 - Zacks Investment Research Upgrades Augmedix (OTCMKTS ...

Finally, Redmile Group LLC acquired a new stake in Augmedix in the fourth quarter valued at approximately $45,298,000.

2022-04-20 - Medical Devices industry deals in March 2022: GlobalData

3) Fidelity Management & Research,Redmile Group and T Rowe Price Associates $125m private equity deal with Saluda Medical.

2022-04-17 - Biotech venture capital: Top 10 money-raisers of 2021

Investors: RA Capital Management, Redmile Group, Federated Hermes, ... than 10-year-old biotech, owned by Czech investment firm PPF Group,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.5M7519%$31.9M
#2
$9.5M75-5%$51M
#3
$25.9M754%N/A
#4
$12.5M75-13%N/A
#5
$9.8M75N/AN/A